home / stock / vapo / vapo quote
Last: | $1.27 |
---|---|
Change Percent: | 1.68% |
Open: | $1.17 |
Close: | $1.27 |
High: | $1.45 |
Low: | $1.1138 |
Volume: | 174,896 |
Last Trade Date Time: | 12/14/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.27 | $1.17 | $1.27 | $1.45 | $1.1138 | 174,896 | 12-14-2023 |
$1.19 | $1.18 | $1.19 | $1.25 | $0.9879 | 213,381 | 12-13-2023 |
$1.17 | $1.4 | $1.17 | $1.49 | $1.16 | 174,491 | 12-12-2023 |
$1.5 | $1.59 | $1.5 | $1.67 | $1.47 | 252,498 | 12-11-2023 |
$1.97 | $2.03 | $1.97 | $2.05 | $1.86 | 33,467 | 12-08-2023 |
$2 | $2.16 | $2 | $2.225 | $1.96 | 94,979 | 12-07-2023 |
$2.17 | $2.27 | $2.17 | $2.33 | $2.17 | 42,450 | 12-06-2023 |
$2.27 | $2.41 | $2.27 | $2.41 | $2.2 | 36,630 | 12-05-2023 |
$2.39 | $2.595 | $2.39 | $2.595 | $2.38 | 26,959 | 12-04-2023 |
$2.54 | $2.69 | $2.54 | $2.7486 | $2.5 | 10,900 | 12-01-2023 |
$2.69 | $2.96 | $2.69 | $2.96 | $2.61 | 28,223 | 11-30-2023 |
$3.02 | $3.29 | $3.02 | $3.44 | $2.94 | 40,599 | 11-29-2023 |
$3.25 | $2.993 | $3.25 | $3.43 | $2.993 | 99,721 | 11-28-2023 |
$3 | $2.82 | $3 | $3.06 | $2.72 | 21,777 | 11-27-2023 |
$2.84 | $2.6979 | $2.84 | $2.84 | $2.65 | 9,185 | 11-24-2023 |
$2.62 | $2.62 | $2.62 | $2.75 | $2.62 | 17,249 | 11-23-2023 |
$2.62 | $2.62 | $2.62 | $2.75 | $2.62 | 17,249 | 11-22-2023 |
$2.65 | $2.5 | $2.65 | $2.73 | $2.5 | 10,237 | 11-21-2023 |
$2.52 | $2.55 | $2.52 | $2.7689 | $2.4717 | 40,863 | 11-20-2023 |
$2.55 | $2.55 | $2.55 | $2.68 | $2.55 | 13,618 | 11-17-2023 |
News, Short Squeeze, Breakout and More Instantly...
Onymos and Vapotherm Announce Partnership to Create an End-to-End Internet of Medical Things Solution (IoMT) PR Newswire Partnership enables Vapotherm to build a robust and secure solution 80% faster than the standard development timeline to meet data visualization and de...
Vapotherm to Unveil Access365 Home Ventilation Solution at MEDTRADE PR Newswire EXETER, N.H. , March 15, 2024 /PRNewswire/ -- Vapotherm, Inc., (OTCQX: VAPO), ("Vapotherm" or the "Company") today announced the debut of its Access365™ Home Ventilation Soluti...
Dr. David Yamane was awarded the Star Research Award at the 2024 Critical Care Congress for the presentation of the HYPERACT Study - a randomized controlled trial demonstrating Vapotherm's High Velocity Therapy effectively treats moderate-severe acute exacerbations of COPD, while improving patien...